“Proof of principle” established for CBD’s potential to prevent drug relapse
ENFLEUR is pleased to share a 2018 study appearing in Neuropsychopharmacology, an international journal focused on contributions that advance the understanding of the brain and behavior. This study remarks on the how CBD improved impulsivity related to alcohol and reduced both stress- and context-induced drug seeking (alcohol and cocaine) in rat models. In both animal and human models, CBD has proven anxiolytic (anti-anxiety) properties. Ultimately, the study notes that the results record two unique therapeutic dimensions of CBD in terms of drug relapse prevention: first, CBD has beneficial effects in moderating several relapse-promoting conditions, and second, CBD has long-lasting therapeutic effects in two investigated reinstatement models of relapse, and heroin, as previously reported in another study. CBD has shown efficacy in reducing alcohol and cocaine reinstatement, as well as heroin in another study.
CBD has also been shown to be proven and effective in pain management, as an anxiolytic (anti-anxiety), and anti-inflammatory agent. Owing to its ability to interact both directly and indirectly with the body’s ECS (endocannabinoid system), there is sufficient reason to consider the potential benefit of integrating high quality CBD into a daily wellness regime.
Why does this matter? Study finds that the therapeutic potential for CBD in addiction treatment is indicated across several classes of abused drugs.